Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/17/2025

Relationship Between hEDS, MCAS, and Obesity

Pathophysiological Considerations

  • The American Gastroenterological Association notes that hEDS is characterized by connective tissue abnormalities with softer, less stiff connective tissue than in control subjects, which affects collagen fibril structure and triggers fibroblast dysfunction 2
  • The American Gastroenterological Association states that MCAS involves abnormal mast cell activation causing release of histamine, heparin, and various cytokines into surrounding tissues, affecting multiple body systems including skin, soft tissue, gastrointestinal tract, respiratory tract, and cardiovascular system 2, 3
  • Current clinical guidelines do not identify a direct mechanistic link between hEDS, MCAS, and predisposition to obesity, as reported by the American Gastroenterological Association 1, 2, 3

Associated Conditions That May Indirectly Affect Weight

Gastrointestinal Manifestations

  • Patients with hEDS frequently report gastrointestinal symptoms, which may affect nutritional status and eating patterns, according to the American Gastroenterological Association 1, 2
  • Common GI manifestations include gastroesophageal reflux disease, as noted by the American Gastroenterological Association 3
  • Delayed gastric emptying is also a common GI manifestation in patients with hEDS, as reported by the American Gastroenterological Association 1
  • Irritable bowel syndrome is another common GI manifestation in patients with hEDS, according to the American Gastroenterological Association 2

Dietary Interventions

  • Patients with hEDS and MCAS often follow specialized diets, such as low-histamine diets for MCAS, which may affect nutritional intake and weight, as noted by the American Gastroenterological Association 1
  • Gastroparesis diets and various elimination diets may also be used, which should be delivered with appropriate nutritional counseling to avoid restrictive eating patterns, according to the American Gastroenterological Association 1

Clinical Implications

  • When managing patients with hEDS and/or MCAS who are concerned about weight, focus on treating the most prominent symptoms and abnormal GI function test results, as recommended by the American Gastroenterological Association 1
  • Consider the impact of medications on weight and metabolism, and provide nutritional counseling when implementing dietary interventions, according to the American Gastroenterological Association 1